Adult Solid Tumor Clinical Trials
26 clinical trials for Adult Solid Tumor across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC — RECRUITING · PHASE2
- Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC — RECRUITING · PHASE2
- Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours — RECRUITING · PHASE1
- A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors — COMPLETED · PHASE1
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) — ACTIVE_NOT_RECRUITING · PHASE2
- Combining Epigenetic And Immune Therapy to Beat Cancer. — COMPLETED · PHASE2
- Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults — COMPLETED · PHASE1
- Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer — ACTIVE_NOT_RECRUITING · PHASE2
- Study of RP-6306 With Gemcitabine in Advanced Solid Tumors — TERMINATED · PHASE1
- Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling — COMPLETED
- Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors — TERMINATED
- Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy — COMPLETED · PHASE3
- A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor — NOT_YET_RECRUITING · PHASE1
- Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors — TERMINATED · PHASE1
- Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors — TERMINATED · PHASE1
- Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor — COMPLETED · PHASE1
- Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors — COMPLETED · PHASE1
- Study of LTC004 in Subjects With Advanced Malignant Tumors — OTHER · PHASE1
- Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence — COMPLETED · NA
- A Phase I Trial of AZD3965 in Patients With Advanced Cancer — COMPLETED · PHASE1
- Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer — COMPLETED · PHASE2
- Hydrogen Gas for Cancer Rehabilitation — COMPLETED · NA
- CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2 — SUSPENDED
- Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated — COMPLETED · PHASE1
- A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain — COMPLETED · NA
- Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery — WITHDRAWN · PHASE3
Refine this search